ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Chinese drugmaker gives trial coronavirus vaccine to staff

Nasdaq-listed Sinovac Biotech hopes to get production license this year

SHANGHAI - Chinese drugmaker Sinovac Biotech has begun to administer a coronavirus vaccine to thousands of its staff as the race to secure an immunization for COVID-19 enters advanced clinical trials.

Some 3,000 employees and family members had been injected with the vaccine developed by the Nasdaq-listed company, according to the Sina Finance website and other reports quoting a Sinovac spokesperson on Sunday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more